HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Dentin hypersensitivity treated with a fluoride-containing varnish or a light-cured glass-ionomer liner.

Abstract
Dentin hypersensitivity in 112 teeth was randomly treated with Duraphat or Vitrabond. No patients were included unless they, without being asked, complained about daily pain for a long period of time caused by cold, warm, sweet, sour, touch or any combination of these five variables. Patients were excluded if the dentin hypersensitivity could have been caused by cervical abrasion/erosion lesions deeper than 1 mm, cracked-tooth syndrome, caries lesions, operative caries treatment, and/or periodontal surgery or root scaling within the last 6 months. The pain was registered on a binary scale: 1) pain before the treatment; and 2) pain/no pain after the treatment. With Duraphat, 22% of the treatments failed within 1 wk and the cumulative 1-yr success rate was 41%. With Vitrabond, 2% failed within the first week and the 1-yr success rate was 79%. The difference between the two treatments was highly significant. Patients in whom Duraphat failed were treated with Vitrabond and vice versa; the 1-yr success rate for the retreated teeth was 68% when "Duraphat-failures" were treated with Vitrabond and 42% when "Vitrabond-failures" were treated with Duraphat.
AuthorsE K Hansen
JournalScandinavian journal of dental research (Scand J Dent Res) Vol. 100 Issue 6 Pg. 305-9 (Dec 1992) ISSN: 0029-845X [Print] Denmark
PMID1465561 (Publication Type: Clinical Trial, Comparative Study, Journal Article, Randomized Controlled Trial)
Chemical References
  • Dentin-Bonding Agents
  • Fluorides, Topical
  • Glass Ionomer Cements
  • sodium fluoride topical preparation
  • Vitrabond
  • Sodium Fluoride
Topics
  • Adult
  • Bicuspid
  • Cold Temperature (adverse effects)
  • Cuspid
  • Dental Cavity Lining
  • Dentin Sensitivity (etiology, prevention & control)
  • Dentin-Bonding Agents (therapeutic use)
  • Female
  • Fluorides, Topical (therapeutic use)
  • Glass Ionomer Cements (therapeutic use)
  • Humans
  • Male
  • Middle Aged
  • Sodium Fluoride (therapeutic use)
  • Touch
  • Treatment Failure

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: